Patent · US Active

1,4-diaryl-pyrimidopyridazine-2,5-diones and their use

US8580800B2 · kind B2 · utility

11Cited by

0References

9Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Franz Von Nussbaum · Mülheim an der Ruhr, DE
Dagmar Karthaus · Solingen, DE
Martina Delbeck · Essen, DE
Volkhart Min-Jian Li · Velbert, DE
Daniel Meibom · Leverkusen, DE
Klemens Lustig · Wuppertal, DE

Key dates

Filing date	Apr 24, 2009
Grant date	Nov 12, 2013
Priority date	—
Expiry date	Apr 24, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel 1,4-diarylpyrimido[4,5-d]pyridazine-2,5-dione derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.